David Capellaro
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 2
-
- RNA Interference and Gene Delivery 2
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Melvyn F. Greaves (7 shared papers)A H Goldstone (3 shared papers)G. E. Brown (2 shared papers)Jeremy R. Jass (2 shared papers)George Janossy (4 shared papers)Rob Shields (1 shared paper)Robert F. Brooks (1 shared paper)Peter N. Riddle (1 shared paper)
- Journals
- British Journal of Haematology (3 papers)Nature (1 paper)Cell (1 paper)Gastroenterology (1 paper)Blood (1 paper)
- Partner nations
- United KingdomUnited StatesHungary
In The Last Decade
David Capellaro
12 papers receiving 597 citations
Peers
Comparison fields: 5 of 69
- Hematology 190
- Genetics 97
- Pathology and Forensic Medicine 119
- Immunology 127
- Cancer Research 76
Countries citing papers authored by David Capellaro
This map shows the geographic impact of David Capellaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Capellaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Capellaro more than expected).
Fields of papers citing papers by David Capellaro
This network shows the impact of papers produced by David Capellaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Capellaro. The network helps show where David Capellaro may publish in the future.
Co-authors
The 25 scholars most cited alongside David Capellaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 98 | |
| 2 | 1978 | 96 | |
| 3 | 1978 | 83 | |
| 4 | 1975 | 82 | |
| 5 | 1977 | 80 | |
| 6 | 1978 | 75 | |
| 7 | 1989 | 74 | |
| 8 | 1976 | 20 | |
| 9 | 1977 | 18 | |
| 10 | 1986 | 17 | |
| 11 | 1987 | 14 | |
| 12 | 1976 | 6 |
About David Capellaro
David Capellaro is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology and Surgery, having authored 12 papers that have together received 663 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Acute Myeloid Leukemia Research (2 papers), Immunotherapy and Immune Responses (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), RNA Interference and Gene Delivery (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (190 citations), Genetics (97 citations), Pathology and Forensic Medicine (119 citations), Immunology (127 citations) and Cancer Research (76 citations). David Capellaro has collaborated with scholars based in United Kingdom, United States and Hungary. Frequent co-authors include Melvyn F. Greaves, A H Goldstone, G. E. Brown, Jeremy R. Jass, George Janossy, Rob Shields, Robert F. Brooks, Peter N. Riddle, H. S. Goh and Sharon Love. Their work appears in journals such as British Journal of Haematology, Nature, Cell, Gastroenterology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.